Structure

Physi-Chem Properties

Molecular Weight:  288.14
Volume:  304.817
LogP:  2.935
LogD:  3.372
LogS:  -3.866
# Rotatable Bonds:  6
TPSA:  47.92
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  2
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.886
Synthetic Accessibility Score:  1.747
Fsp3:  0.294
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.819
MDCK Permeability:  1.901367613754701e-05
Pgp-inhibitor:  0.979
Pgp-substrate:  0.92
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.105
30% Bioavailability (F30%):  0.2

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.129
Plasma Protein Binding (PPB):  96.28074645996094%
Volume Distribution (VD):  0.871
Pgp-substrate:  1.7205241918563843%

ADMET: Metabolism

CYP1A2-inhibitor:  0.956
CYP1A2-substrate:  0.967
CYP2C19-inhibitor:  0.944
CYP2C19-substrate:  0.867
CYP2C9-inhibitor:  0.816
CYP2C9-substrate:  0.887
CYP2D6-inhibitor:  0.724
CYP2D6-substrate:  0.942
CYP3A4-inhibitor:  0.895
CYP3A4-substrate:  0.734

ADMET: Excretion

Clearance (CL):  12.521
Half-life (T1/2):  0.843

ADMET: Toxicity

hERG Blockers:  0.365
Human Hepatotoxicity (H-HT):  0.136
Drug-inuced Liver Injury (DILI):  0.503
AMES Toxicity:  0.058
Rat Oral Acute Toxicity:  0.021
Maximum Recommended Daily Dose:  0.273
Skin Sensitization:  0.927
Carcinogencity:  0.193
Eye Corrosion:  0.039
Eye Irritation:  0.452
Respiratory Toxicity:  0.238

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470626

Natural Product ID:  NPC470626
Common Name*:   5-[2-(3,4-Dimethoxyphenyl)Ethyl]-2-Methoxyphenol
IUPAC Name:   5-[2-(3,4-dimethoxyphenyl)ethyl]-2-methoxyphenol
Synonyms:  
Standard InCHIKey:  UPOANTHMCQBWOE-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C17H20O4/c1-19-15-8-6-12(10-14(15)18)4-5-13-7-9-16(20-2)17(11-13)21-3/h6-11,18H,4-5H2,1-3H3
SMILES:  COC1=C(C=C(C=C1)CCC2=CC(=C(C=C2)OC)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2093988
PubChem CID:   152354
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000253] Stilbenes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32832 combretum caffrum Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[19228038]
NPO32832 combretum caffrum Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[3404149]
NPO32832 combretum caffrum Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[3598594]
NPO32832 combretum caffrum Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[3668557]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT137 Cell Line L1210 Mus musculus IC50 = 3000.0 nM PMID[486686]
NPT137 Cell Line L1210 Mus musculus Activity = 25.0 % PMID[486686]
NPT81 Cell Line A549 Homo sapiens IC50 = 4790.0 nM PMID[486687]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 4050.0 nM PMID[486687]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 81.0 nM PMID[486687]
NPT1097 Cell Line MKN-45 Homo sapiens IC50 > 25000.0 nM PMID[486687]
NPT393 Cell Line HCT-116 Homo sapiens IC50 = 5260.0 nM PMID[486687]
NPT2 Others Unspecified Inhibition = 7.0 % PMID[486686]
NPT2 Others Unspecified Inhibition = 19.0 % PMID[486686]
NPT2 Others Unspecified Inhibition = 71.0 % PMID[486686]
NPT2 Others Unspecified IC50 > 100000.0 nM PMID[486686]
NPT617 Organism Danio rerio Danio rerio MED = 40.0 uM PMID[486687]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470626 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9909 High Similarity NPC293619
0.9821 High Similarity NPC95614
0.9821 High Similarity NPC165133
0.9821 High Similarity NPC56214
0.9821 High Similarity NPC117780
0.9821 High Similarity NPC227217
0.9821 High Similarity NPC242885
0.9821 High Similarity NPC232316
0.9735 High Similarity NPC207613
0.9732 High Similarity NPC310338
0.9732 High Similarity NPC281298
0.9649 High Similarity NPC343720
0.9649 High Similarity NPC184651
0.9649 High Similarity NPC324571
0.9649 High Similarity NPC470212
0.9649 High Similarity NPC113865
0.9649 High Similarity NPC160380
0.9649 High Similarity NPC54872
0.9649 High Similarity NPC38996
0.9649 High Similarity NPC312675
0.9649 High Similarity NPC473853
0.9649 High Similarity NPC262156
0.9565 High Similarity NPC85488
0.9483 High Similarity NPC471693
0.9483 High Similarity NPC317769
0.9483 High Similarity NPC280704
0.9483 High Similarity NPC31344
0.9386 High Similarity NPC311595
0.9386 High Similarity NPC24474
0.9381 High Similarity NPC164386
0.9381 High Similarity NPC86947
0.9364 High Similarity NPC173746
0.9364 High Similarity NPC8547
0.9364 High Similarity NPC156840
0.9364 High Similarity NPC257124
0.9322 High Similarity NPC251855
0.9322 High Similarity NPC9067
0.9322 High Similarity NPC266705
0.9322 High Similarity NPC53305
0.9322 High Similarity NPC472093
0.9322 High Similarity NPC117214
0.9322 High Similarity NPC208950
0.9322 High Similarity NPC29008
0.9322 High Similarity NPC475169
0.9322 High Similarity NPC57490
0.9322 High Similarity NPC193544
0.9322 High Similarity NPC233410
0.9322 High Similarity NPC203133
0.9322 High Similarity NPC221077
0.9322 High Similarity NPC228771
0.9322 High Similarity NPC257589
0.9322 High Similarity NPC116907
0.9322 High Similarity NPC17943
0.9322 High Similarity NPC298757
0.9322 High Similarity NPC148627
0.9316 High Similarity NPC197757
0.9316 High Similarity NPC228922
0.931 High Similarity NPC127389
0.931 High Similarity NPC290451
0.9298 High Similarity NPC474040
0.9298 High Similarity NPC474214
0.9244 High Similarity NPC127937
0.9244 High Similarity NPC92207
0.9244 High Similarity NPC304630
0.9244 High Similarity NPC274356
0.9244 High Similarity NPC17837
0.9231 High Similarity NPC41562
0.9224 High Similarity NPC14007
0.9224 High Similarity NPC60962
0.9224 High Similarity NPC189844
0.9224 High Similarity NPC224814
0.9224 High Similarity NPC109083
0.9224 High Similarity NPC269843
0.9217 High Similarity NPC474320
0.9196 High Similarity NPC165106
0.9182 High Similarity NPC246358
0.9182 High Similarity NPC233731
0.9182 High Similarity NPC7097
0.9182 High Similarity NPC36108
0.9167 High Similarity NPC293054
0.9167 High Similarity NPC118533
0.9167 High Similarity NPC82679
0.9167 High Similarity NPC21563
0.9167 High Similarity NPC324112
0.9167 High Similarity NPC106511
0.9167 High Similarity NPC246620
0.9167 High Similarity NPC282000
0.9167 High Similarity NPC124452
0.9167 High Similarity NPC169474
0.9167 High Similarity NPC74817
0.9167 High Similarity NPC159968
0.9167 High Similarity NPC5428
0.9167 High Similarity NPC127587
0.9167 High Similarity NPC165045
0.9167 High Similarity NPC236791
0.916 High Similarity NPC194519
0.9153 High Similarity NPC282496
0.9153 High Similarity NPC136319
0.9153 High Similarity NPC233526
0.9091 High Similarity NPC474178
0.9091 High Similarity NPC45774
0.9091 High Similarity NPC11258
0.9091 High Similarity NPC128208
0.9091 High Similarity NPC470213
0.9091 High Similarity NPC252307
0.9091 High Similarity NPC307050
0.9091 High Similarity NPC186843
0.9091 High Similarity NPC98631
0.9091 High Similarity NPC245826
0.9091 High Similarity NPC282703
0.9091 High Similarity NPC184733
0.9091 High Similarity NPC21867
0.9091 High Similarity NPC75440
0.9091 High Similarity NPC277458
0.9091 High Similarity NPC226661
0.9091 High Similarity NPC206615
0.9091 High Similarity NPC129570
0.9083 High Similarity NPC120225
0.9083 High Similarity NPC214406
0.9083 High Similarity NPC303680
0.9083 High Similarity NPC44748
0.9083 High Similarity NPC18924
0.9083 High Similarity NPC28730
0.9083 High Similarity NPC76451
0.9083 High Similarity NPC191037
0.9083 High Similarity NPC178284
0.9083 High Similarity NPC58607
0.9083 High Similarity NPC78974
0.9083 High Similarity NPC223136
0.9083 High Similarity NPC84076
0.9083 High Similarity NPC90128
0.9083 High Similarity NPC213552
0.9083 High Similarity NPC103823
0.9076 High Similarity NPC114901
0.9076 High Similarity NPC293701
0.9076 High Similarity NPC48990
0.9068 High Similarity NPC30462
0.9068 High Similarity NPC473411
0.9068 High Similarity NPC262253
0.9068 High Similarity NPC71579
0.9035 High Similarity NPC475815
0.9035 High Similarity NPC47194
0.9035 High Similarity NPC473264
0.9018 High Similarity NPC139617
0.9018 High Similarity NPC78918
0.9018 High Similarity NPC195873
0.9016 High Similarity NPC212015
0.9016 High Similarity NPC170844
0.9016 High Similarity NPC476968
0.9016 High Similarity NPC304622
0.9016 High Similarity NPC475875
0.9008 High Similarity NPC123228
0.9008 High Similarity NPC147821
0.9008 High Similarity NPC41706
0.9008 High Similarity NPC163332
0.9008 High Similarity NPC151167
0.9008 High Similarity NPC292056
0.9008 High Similarity NPC319625
0.9008 High Similarity NPC276466
0.9008 High Similarity NPC111247
0.9008 High Similarity NPC252131
0.9008 High Similarity NPC123722
0.9008 High Similarity NPC210355
0.9008 High Similarity NPC183181
0.9008 High Similarity NPC118787
0.9008 High Similarity NPC5018
0.9 High Similarity NPC234400
0.9 High Similarity NPC289459
0.9 High Similarity NPC82483
0.9 High Similarity NPC299584
0.9 High Similarity NPC60885
0.9 High Similarity NPC265483
0.9 High Similarity NPC105925
0.8992 High Similarity NPC229084
0.8992 High Similarity NPC18984
0.8992 High Similarity NPC163083
0.8992 High Similarity NPC160900
0.8992 High Similarity NPC121115
0.8992 High Similarity NPC249788
0.8992 High Similarity NPC106659
0.8983 High Similarity NPC476343
0.8983 High Similarity NPC201777
0.8974 High Similarity NPC10932
0.8974 High Similarity NPC61516
0.8974 High Similarity NPC474565
0.8974 High Similarity NPC247364
0.8974 High Similarity NPC232084
0.8966 High Similarity NPC255675
0.8957 High Similarity NPC9341
0.8957 High Similarity NPC221049
0.8957 High Similarity NPC81067
0.8943 High Similarity NPC153739
0.8943 High Similarity NPC275724
0.8943 High Similarity NPC65935
0.8943 High Similarity NPC311680
0.8943 High Similarity NPC123196
0.8943 High Similarity NPC241522
0.8943 High Similarity NPC51840
0.8943 High Similarity NPC92164
0.8943 High Similarity NPC275950

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470626 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9364 High Similarity NPD228 Approved
0.9196 High Similarity NPD5283 Phase 1
0.9016 High Similarity NPD3027 Phase 3
0.8992 High Similarity NPD4379 Clinical (unspecified phase)
0.8839 High Similarity NPD3021 Approved
0.8839 High Similarity NPD3022 Approved
0.8403 Intermediate Similarity NPD5536 Phase 2
0.8359 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.8359 Intermediate Similarity NPD3620 Phase 2
0.8333 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8261 Intermediate Similarity NPD2684 Approved
0.8254 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8226 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD1613 Approved
0.814 Intermediate Similarity NPD2674 Phase 3
0.8136 Intermediate Similarity NPD7843 Approved
0.8115 Intermediate Similarity NPD1357 Approved
0.8091 Intermediate Similarity NPD2860 Approved
0.8091 Intermediate Similarity NPD2859 Approved
0.8083 Intermediate Similarity NPD7157 Approved
0.808 Intermediate Similarity NPD2982 Phase 2
0.808 Intermediate Similarity NPD2983 Phase 2
0.8077 Intermediate Similarity NPD1558 Phase 1
0.8077 Intermediate Similarity NPD4060 Phase 1
0.8036 Intermediate Similarity NPD3020 Approved
0.8 Intermediate Similarity NPD2981 Phase 2
0.8 Intermediate Similarity NPD2933 Approved
0.8 Intermediate Similarity NPD2934 Approved
0.8 Intermediate Similarity NPD9296 Approved
0.7969 Intermediate Similarity NPD3018 Phase 2
0.7934 Intermediate Similarity NPD6671 Approved
0.7923 Intermediate Similarity NPD3144 Approved
0.7923 Intermediate Similarity NPD5111 Phase 2
0.7923 Intermediate Similarity NPD5110 Phase 2
0.7923 Intermediate Similarity NPD3145 Approved
0.7923 Intermediate Similarity NPD5109 Approved
0.7891 Intermediate Similarity NPD6584 Phase 3
0.7881 Intermediate Similarity NPD5451 Approved
0.7868 Intermediate Similarity NPD3060 Approved
0.7846 Intermediate Similarity NPD7095 Approved
0.7829 Intermediate Similarity NPD9494 Approved
0.7778 Intermediate Similarity NPD3705 Approved
0.7778 Intermediate Similarity NPD968 Approved
0.7769 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.776 Intermediate Similarity NPD5846 Approved
0.776 Intermediate Similarity NPD6516 Phase 2
0.7734 Intermediate Similarity NPD2922 Phase 1
0.7698 Intermediate Similarity NPD3847 Discontinued
0.7692 Intermediate Similarity NPD2861 Phase 2
0.7686 Intermediate Similarity NPD5535 Approved
0.7656 Intermediate Similarity NPD6582 Phase 2
0.7656 Intermediate Similarity NPD6583 Phase 3
0.7652 Intermediate Similarity NPD5718 Phase 2
0.7643 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD4908 Phase 1
0.763 Intermediate Similarity NPD6896 Approved
0.763 Intermediate Similarity NPD6895 Approved
0.7619 Intermediate Similarity NPD2668 Approved
0.7619 Intermediate Similarity NPD2667 Approved
0.7619 Intermediate Similarity NPD4626 Approved
0.7609 Intermediate Similarity NPD4162 Approved
0.7578 Intermediate Similarity NPD2232 Approved
0.7578 Intermediate Similarity NPD2230 Approved
0.7578 Intermediate Similarity NPD2233 Approved
0.7563 Intermediate Similarity NPD290 Approved
0.7554 Intermediate Similarity NPD6331 Phase 2
0.7554 Intermediate Similarity NPD4110 Phase 3
0.7554 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD1651 Approved
0.7522 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.7519 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7519 Intermediate Similarity NPD6798 Discontinued
0.7519 Intermediate Similarity NPD1669 Approved
0.75 Intermediate Similarity NPD1610 Phase 2
0.75 Intermediate Similarity NPD5241 Discontinued
0.7482 Intermediate Similarity NPD5177 Phase 3
0.7482 Intermediate Similarity NPD4237 Approved
0.7482 Intermediate Similarity NPD4236 Phase 3
0.7481 Intermediate Similarity NPD6355 Discontinued
0.7481 Intermediate Similarity NPD4624 Approved
0.7481 Intermediate Similarity NPD3657 Discovery
0.7466 Intermediate Similarity NPD1934 Approved
0.7464 Intermediate Similarity NPD7266 Discontinued
0.7463 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD1283 Approved
0.746 Intermediate Similarity NPD1548 Phase 1
0.7456 Intermediate Similarity NPD844 Approved
0.7445 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7445 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD291 Approved
0.7417 Intermediate Similarity NPD1358 Approved
0.7415 Intermediate Similarity NPD2977 Approved
0.7415 Intermediate Similarity NPD2978 Approved
0.7415 Intermediate Similarity NPD2801 Approved
0.741 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD3053 Approved
0.7405 Intermediate Similarity NPD3055 Approved
0.7398 Intermediate Similarity NPD9377 Approved
0.7398 Intermediate Similarity NPD821 Approved
0.7398 Intermediate Similarity NPD9379 Approved
0.7391 Intermediate Similarity NPD2935 Discontinued
0.7391 Intermediate Similarity NPD2161 Phase 2
0.7372 Intermediate Similarity NPD4538 Approved
0.7372 Intermediate Similarity NPD4536 Approved
0.7372 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD709 Approved
0.7353 Intermediate Similarity NPD5735 Approved
0.735 Intermediate Similarity NPD1242 Phase 1
0.7343 Intermediate Similarity NPD4123 Phase 3
0.7338 Intermediate Similarity NPD3540 Phase 1
0.7338 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6233 Phase 2
0.7333 Intermediate Similarity NPD4062 Phase 3
0.7328 Intermediate Similarity NPD5310 Approved
0.7328 Intermediate Similarity NPD5311 Approved
0.7328 Intermediate Similarity NPD8651 Approved
0.7315 Intermediate Similarity NPD3882 Suspended
0.7313 Intermediate Similarity NPD4625 Phase 3
0.7308 Intermediate Similarity NPD2235 Phase 2
0.7308 Intermediate Similarity NPD2231 Phase 2
0.7305 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7302 Intermediate Similarity NPD3596 Phase 2
0.7297 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7287 Intermediate Similarity NPD3496 Discontinued
0.7286 Intermediate Similarity NPD2808 Discontinued
0.7273 Intermediate Similarity NPD4357 Discontinued
0.7266 Intermediate Similarity NPD5691 Approved
0.7266 Intermediate Similarity NPD3539 Phase 1
0.7254 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7252 Intermediate Similarity NPD4749 Approved
0.7252 Intermediate Similarity NPD5327 Phase 3
0.7241 Intermediate Similarity NPD288 Approved
0.7236 Intermediate Similarity NPD9280 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD6674 Discontinued
0.7234 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7231 Intermediate Similarity NPD1535 Discovery
0.7231 Intermediate Similarity NPD1281 Approved
0.7231 Intermediate Similarity NPD3092 Approved
0.7222 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6234 Discontinued
0.7214 Intermediate Similarity NPD1375 Discontinued
0.7203 Intermediate Similarity NPD3028 Approved
0.7203 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD7124 Phase 2
0.7194 Intermediate Similarity NPD5588 Approved
0.7194 Intermediate Similarity NPD5960 Phase 3
0.719 Intermediate Similarity NPD3134 Approved
0.7188 Intermediate Similarity NPD1894 Discontinued
0.7188 Intermediate Similarity NPD3091 Approved
0.7188 Intermediate Similarity NPD6581 Approved
0.7188 Intermediate Similarity NPD6580 Approved
0.7188 Intermediate Similarity NPD1182 Approved
0.7185 Intermediate Similarity NPD2669 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD8166 Discontinued
0.7183 Intermediate Similarity NPD4628 Phase 3
0.7182 Intermediate Similarity NPD111 Approved
0.7176 Intermediate Similarity NPD1481 Phase 2
0.7176 Intermediate Similarity NPD1608 Approved
0.7174 Intermediate Similarity NPD4097 Suspended
0.7163 Intermediate Similarity NPD7153 Discontinued
0.7153 Intermediate Similarity NPD1511 Approved
0.7153 Intermediate Similarity NPD3062 Approved
0.7153 Intermediate Similarity NPD4140 Approved
0.7153 Intermediate Similarity NPD3061 Approved
0.7153 Intermediate Similarity NPD3059 Approved
0.7153 Intermediate Similarity NPD2238 Phase 2
0.7143 Intermediate Similarity NPD3094 Phase 2
0.7143 Intermediate Similarity NPD4005 Discontinued
0.7143 Intermediate Similarity NPD846 Approved
0.7143 Intermediate Similarity NPD940 Approved
0.7143 Intermediate Similarity NPD6032 Approved
0.7132 Intermediate Similarity NPD5585 Approved
0.7132 Intermediate Similarity NPD6830 Clinical (unspecified phase)
0.7132 Intermediate Similarity NPD2028 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD3676 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD3685 Discontinued
0.712 Intermediate Similarity NPD7635 Approved
0.7114 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD37 Approved
0.7103 Intermediate Similarity NPD4584 Approved
0.7101 Intermediate Similarity NPD4340 Discontinued
0.7099 Intermediate Similarity NPD1091 Approved
0.7097 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD6166 Phase 2
0.7097 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD7028 Phase 2
0.7095 Intermediate Similarity NPD4678 Approved
0.7095 Intermediate Similarity NPD4675 Approved
0.7092 Intermediate Similarity NPD5763 Approved
0.7092 Intermediate Similarity NPD5762 Approved
0.709 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7087 Intermediate Similarity NPD2557 Approved
0.7087 Intermediate Similarity NPD6387 Discontinued
0.7086 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.708 Intermediate Similarity NPD9295 Approved
0.7078 Intermediate Similarity NPD4010 Discontinued
0.7077 Intermediate Similarity NPD9384 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data